Clinical Trial Details
Braintumor Website

[Information provided by:, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT03633955 : Pilot Imaging Study of Leukemia
AgesMin: 4 Years Max: 80 Years
Inclusion Criteria:

- Aged 4 to 80 years

- Evidence of high risk hematopoietic malignancy with relapsed/refractory disease and/or
high risk for relapse.

o Acute lymphocytic leukemia, Acute myeloid leukemia, Chronic myelogenous leukemia,
Ambiguous lineage leukemia or lymphoma, or myelodysplastic syndrome

- Karnofsky/Lansky score of = 50

- Agree to use contraceptive measures during study protocol participation (when age

- Patient or parent/guardian capable of providing informed consent.

- Bilirubin < 2.5 mg/dL, AST/ALT <5x upper limit of normal, Serum creatinine < 1.0 or 2x
the upper limit of normal (whichever is higher)

- Pulse oximetry of > 90% on room air

- Ability to undergo 18F FLT imaging without sedation

- Anticipated immunotherapy (Arm A to include patients who received immune therapy with
TAA-L cells (RESOLVE co-enrollment) or other immunotherapy) and ARM B, those who
received other non-immune therapies to treat their cancers (excludes HSCT but includes
chemotherapy or non-HSCT radiotherapy).

Exclusion Criteria:

- Patients with uncontrolled infections

- Pregnancy or lactating

- History of prior fluorothymidine allergy or intolerance
LinksPermanent Link to THIS page:      |      Link to official listing

Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2020 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557